Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records
This article was originally published in The Tan Sheet
Executive Summary
An FDA task force will review the 13,000 ephedrine alkaloid patient complaint records Metabolife is releasing in response to publicity surrounding a criminal investigation into whether the company lied about its knowledge of adverse events